We analyzed treatment results in regard to survival and local metastasis control.
2
Background: Reliable method to predict lymph node metastasis is not yet available.
3
Purpose: To review the available options of percutaneous ablation of lung metastasis.
4
Outcomes: No recurrence or metastasis occurred during 50 months after the operation.
5
However, no local recurrence or metastasis has been detected 2 months post-surgery.
1
Background: Tumor angiogenesis is essential for primary and metastatictumor growth.
2
We investigated the hypothesis that ASCs have an inhibitory effect on metastatictumor progression.
3
Bone marrow provides a unique microenvironment favoring the colonization and outgrowth of metastatictumor cells.
4
Conclusions: A metastatictumor was the only independently significant unfavorable factor for local control after SBRT.
5
Methods: Patients undergoing a clinically indicated metastatictumor biopsy were consented to the ongoing METAMORPH registry.
Ús de secondary tumor en anglès
1
With mean follow up of 37 months, neither relapse nor secondarytumor was observed.
2
Protective immune responses were also observed following secondarytumor challenge.
3
CD70 expression enhanced primary tumor rejection in vivo as well as T cell immunity against secondarytumor challenge.
4
CD80 expression enhanced primary NK cell-mediated tumor rejection in vivo and T cell immunity against secondarytumor challenge.
5
Such ability suggests that the primary tumor is producing inhibitors that act at the site of the secondarytumor.
6
Both of these lesions are mutagenic and may contribute to secondarytumor development, a major clinical limitation of NM chemotherapy.
7
We studied 11 cases of malignant melanomas that required careful histopathological and immunohistochemical analysis to differentiate between primary and secondarytumor.
8
Despite its high rate of efficacy, radiotherapy (RT) is often avoided due to fear of inducing a secondarytumor.
9
Finally, few data show a benefit from secondarytumor resection in patients who progress while undergoing first-line chemotherapy or have a recurrence soon afterward.
10
Additionally, absence of TGF-β1 in T cells prevented tumors from advancing to higher pathological grades and further suppressed secondarytumor development in the lungs.
11
Introduction: The development of secondarytumors is a well-known late adverse event after urinary diversion.
12
Such interaction is an important step toward the establishment of thriving secondarytumors during blood-borne metastasis.
13
Most of the secondarytumors originating in the penis have primaries from prostate, urinary bladder, and gastrointestinal tract.
14
The rest of them had a relapses or secondarytumors in a different location than the original cancer.
15
However, the frequency of secondarytumors after an ileal conduit is the lowest compared to other methods used for urinary diversion.
16
Expression was heterogeneous across the samples, not different between primary and secondarytumors, and was correlated to PARP1 DNA copy number.